Avenue Therapeutics, Inc. SEC filings ATXI
Avenue Therapeutics, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 30, 2015. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Feb 23, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 16, 2025 | — |
| RW | Filing | Dec 15, 2025 | — |
| 25-NSE | Delisting notice | Jul 18, 2025 | — |
| EFFECT | Filing | May 10, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| EFFECT | Filing | Feb 1, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2024 | — |
| EFFECT | Filing | Oct 31, 2023 | — |
| CORRESP | Letter to the SEC | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2023 | — |
| EFFECT | Filing | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 23, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2023 | — |
| EFFECT | Filing | May 3, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2023 | — |
| D | Filing | Feb 14, 2023 | — |
| EFFECT | Filing | Oct 6, 2022 | — |
| CORRESP | Letter to the SEC | Oct 5, 2022 | — |
| CORRESP | Letter to the SEC | Oct 5, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2022 | — |
| EFFECT | Filing | Dec 10, 2021 | — |
| CORRESP | Letter to the SEC | Dec 9, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2021 | — |
| EFFECT | Filing | Oct 1, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2021 | — |
| EFFECT | Filing | May 4, 2018 | — |
| CORRESP | Letter to the SEC | May 3, 2018 | — |
| CORRESP | Letter to the SEC | May 2, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2018 | — |
| EFFECT | Filing | Jun 26, 2017 | — |
| CERTNAS | Auto-generated paper document | Jun 26, 2017 | — |
| CORRESP | Letter to the SEC | Jun 23, 2017 | — |
| CORRESP | Letter to the SEC | Jun 23, 2017 | — |
| CORRESP | Letter to the SEC | Jun 21, 2017 | — |
| CORRESP | Letter to the SEC | Jun 21, 2017 | — |
| 8-A12B | Filing | Jun 14, 2017 | — |
| CORRESP | Letter to the SEC | Jun 13, 2017 | — |
| CORRESP | Letter to the SEC | Jun 13, 2017 | — |
| CORRESP | Letter to the SEC | Apr 28, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2017 | — |
| CT ORDER | Filing | Apr 5, 2017 | — |
| DRS | Filing | Mar 28, 2017 | — |
| CORRESP | Letter to the SEC | Mar 27, 2017 | — |
| 10-12G/A | Filing | Mar 27, 2017 | — |
| CORRESP | Letter to the SEC | Mar 13, 2017 | — |
| 10-12G/A | Filing | Mar 13, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2017 | — |
| CORRESP | Letter to the SEC | Mar 6, 2017 | — |
| 10-12G/A | Filing | Mar 6, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2017 | — |
| D | Filing | Jan 12, 2017 | — |
| CORRESP | Letter to the SEC | Jan 12, 2017 | — |
| 10-12G | Filing | Jan 12, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 29, 2016 | — |
| RW | Filing | Feb 26, 2016 | — |
| 10-12G/A | Form 10-12g/a | Feb 18, 2016 | — |
| CORRESP | Letter to the SEC | Feb 9, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2016 | — |
| 10-12G | Form 10-12g | Dec 30, 2015 | — |
Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATXI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bay Harbor Islands, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644963
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.